1. Home
  2. UTHR vs CW Comparison

UTHR vs CW Comparison

Compare UTHR & CW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • CW
  • Stock Information
  • Founded
  • UTHR 1996
  • CW 1929
  • Country
  • UTHR United States
  • CW United States
  • Employees
  • UTHR N/A
  • CW N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • CW Industrial Machinery/Components
  • Sector
  • UTHR Health Care
  • CW Technology
  • Exchange
  • UTHR Nasdaq
  • CW Nasdaq
  • Market Cap
  • UTHR 16.2B
  • CW 13.9B
  • IPO Year
  • UTHR 1999
  • CW N/A
  • Fundamental
  • Price
  • UTHR $359.23
  • CW $354.14
  • Analyst Decision
  • UTHR Buy
  • CW Buy
  • Analyst Count
  • UTHR 14
  • CW 5
  • Target Price
  • UTHR $370.86
  • CW $372.40
  • AVG Volume (30 Days)
  • UTHR 313.6K
  • CW 293.4K
  • Earning Date
  • UTHR 02-19-2025
  • CW 02-12-2025
  • Dividend Yield
  • UTHR N/A
  • CW 0.23%
  • EPS Growth
  • UTHR 25.10
  • CW 18.60
  • EPS
  • UTHR 22.72
  • CW 10.58
  • Revenue
  • UTHR $2,756,200,000.00
  • CW $3,082,667,000.00
  • Revenue This Year
  • UTHR $26.32
  • CW $11.55
  • Revenue Next Year
  • UTHR $10.37
  • CW $6.14
  • P/E Ratio
  • UTHR $15.82
  • CW $33.48
  • Revenue Growth
  • UTHR 25.04
  • CW 9.42
  • 52 Week Low
  • UTHR $208.62
  • CW $212.05
  • 52 Week High
  • UTHR $417.82
  • CW $393.40
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 43.90
  • CW 44.13
  • Support Level
  • UTHR $358.82
  • CW $344.11
  • Resistance Level
  • UTHR $383.00
  • CW $385.72
  • Average True Range (ATR)
  • UTHR 9.97
  • CW 10.77
  • MACD
  • UTHR -0.80
  • CW -3.11
  • Stochastic Oscillator
  • UTHR 29.51
  • CW 24.10

About UTHR United Therapeutics Corporation

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

About CW Curtiss-Wright Corporation

Curtiss-Wright Corporation delivers engineered products and services to commercial, defence, power generation, and other industrial markets. It offers industrial vehicle components, control systems and weapons handling systems, pumps, valves, and other solutions. The diversified global company attempts to deliver products on high-performance platforms that require technical sophistication. It has three operating segments based on the markets serviced: Naval & Power which provides coolant pumps, power-dense compact motors, generators, secondary propulsion systems, pumps, pump seals, valves, control rod drive mechanisms, and fastening systems also generate the majority of revenue for the company; Its others segments are Aerospace & Industrial and Defense Electronics.

Share on Social Networks: